GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit www.grail.com
GRAIL is seeking a Director, Billing Operations & Reimbursement who is responsible for helping us build out our billing team & our end-to-end billing processes to ensure accurate & timely benefit investigations, prior authorizations, insurance claims submissions, appeals, patient & client billing. A successful candidate will have the ability to build professional collaborative relationships with cross-functional leaders as well as identify, scope, & execute on strategic projects to drive change. Exceptional knowledge with health plan behaviors in reimbursement & denials is required. Experience leading billing operations at molecular diagnostic or genetic testing companies is a plus.